金吾财讯 | 诺华制药(NVS)第三季度销售净额139.1亿美元,同比增长8.4%,预估138.8亿美元;核心每股收益2.25美元,预估2.26美元;核心净利润43.3亿美元,预估44.2亿美元。公司已两次上调年度业绩预期的诺华维持2025年财务指引,预计销售额将实现"中高个位数"增长,调整后营业利润将实现"低两位数"增长。该股盘前跌2.83%,报125.58美元。
金吾财讯 | 诺华制药(NVS)第三季度销售净额139.1亿美元,同比增长8.4%,预估138.8亿美元;核心每股收益2.25美元,预估2.26美元;核心净利润43.3亿美元,预估44.2亿美元。公司已两次上调年度业绩预期的诺华维持2025年财务指引,预计销售额将实现"中高个位数"增长,调整后营业利润将实现"低两位数"增长。该股盘前跌2.83%,报125.58美元。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.